Diagnostic Testing
Biopsy Breast Modified Radical Mastectomy ER PR HER2 Neu
This test analyzes breast tissue from a modified radical mastectomy to determine hormone receptor status (ER, PR) and HER2/neu protein levels, guiding personalized breast cancer treatment.
General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.
Review status: No completed medical review is recorded for this page.
At a glance
Plan your test
- Sample
- Tissue sample from the modified radical mastectomy.
- Results
- Confirm with the laboratory before booking.
- Preparation
- Confirm with the laboratory before booking. A doctor’s prescription is required.
Payment: M-Pesa and card options can be confirmed during booking.
Insurance & government schemes
Is this test covered for you?
We help you verify whether the Biopsy Breast Modified Radical Mastectomy ER PR HER2 Neu test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.
Providers & schemes we can help you check
Government & public schemes
Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.
Private insurers & employer schemes
Names shown for identification only — listing does not imply partnership or guarantee of coverage.
Have these ready when we check
- Insurer or scheme name & policy / member number
- A clinician's request / prescription for the test
- Pre-authorisation letter, if your plan requires one
Free coverage check
Ask us to verify your cover
Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.
Start with fit
Is this the right test for you?
The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.
- ✓Diagnosis of breast cancer
- ✓Staging of breast cancer
- ✓Treatment planning for breast cancer
- ✓Prognosis assessment in breast cancer
- ✓Guiding therapy selection (hormone therapy, targeted therapy)
- ✓Post-mastectomy analysis
In plain language
What this test helps you understand
This test measures the presence of estrogen receptors (ER), progesterone receptors (PR), and HER2/neu protein in breast tissue samples. These components are critical in understanding the biology of the cancer and how it may respond to specific treatments.
Patients who have been diagnosed with breast cancer, particularly those undergoing a modified radical mastectomy, should consider this test. It helps in determining the most effective treatment plan, provides insight into the cancer's behavior and potential response to therapies, allows for personalized medicine approaches, and facilitates better patient outcomes through informed decision-making.
The results indicate whether the cancer is hormone receptor-positive or HER2-positive. This information is vital for oncologists to recommend appropriate therapies, which may include hormone therapy, chemotherapy, or targeted therapies.
Medical review status
Clinical review pending
A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.
Meet the DNA Labs Kenya medical team →A simple process
What happens next?
You do not have to navigate the test alone. We help you move from question to next step.
Speak with us
We check the test and answer your questions before collection.
Give your sample
Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.
Understand your report
A counselor helps you understand the result and the next steps.
Choose your collection
Home collection or a lab visit
We will explain the sample, preparation, and next steps before anything is collected.
Home collection
Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.
Lab or hub visit
Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.
Ask about locations →Read your report
What common result terms mean
Questions people ask
Frequently asked questions
Collaboration
Open for partnership with hospitals, clinics, doctors & researchers
Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.
Hospitals & clinics
Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.
Doctors & specialists
LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.
Research institutions
Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.
Students & academic projects
Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.
Trust & transparency
Sources, standards & how this page is maintained
Standards & references
- ACMG/AMP technical standards for sequence variant interpretation
- ClinGen curation and gene–disease validity frameworks where applicable
- LOINC-coded reporting for interoperable results
- ISO 9001:2015 quality management; ISO 15189 accreditation in progress
Page provenance
- Last updated: September 27, 2026
- Medical review: not yet completed
- Written for patients & clinicians in Kenya; reviewed periodically against current guidance
Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.
Keep exploring
Related tests
Congenital Hypothyroidism Confirmatory Panel Serum Test
Confirms congenital hypothyroidism in newborns by measuring TSH and Free T4 levels. Early detection is crucial for preventing developmental delays. Available across Kenya.
Learn more →Immunohistochemistry Single Marker With Interpretation Test
A specialized test using immunohistochemistry to detect specific proteins in tumor tissue, aiding in cancer diagnosis and treatment planning.
Learn more →Albumin Fluid Test
The Albumin Fluid Test measures albumin levels in body fluids to help diagnose infections and assess conditions affecting fluid balance. Available across Kenya.
Learn more →Aluminium Plasma Test
Measures aluminium levels in the blood to assess potential exposure, particularly relevant for individuals in industrial settings. Confirm with the laboratory before booking.
Learn more →